my concern are the interim results of the cd12 covid trial.after all way back in july np doing a proactive blurted with no details "quite a few deaths"

also np has mentioned "no reverse" before but in lieu of a possible uplist does he double speak?imo

who is buying leronlimab from the 13 batches samsung is producing for cydy?
$30 million has already been paid to samsung this 2020 with $86 milllion owed
samsung? 7 batches were added to the original 6 being produced this 2020.a possible failure to disclose information in a timely manner? imo